Upgrade to SI Premium - Free Trial

Haemonetics 3rd Quarter Fiscal 2017 Earnings Release Available on Investor Relations Website

February 6, 2017 6:00 AM

BRAINTREE, Mass., Feb. 6, 2017 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that third quarter and year-to-date fiscal year 2017 financial results are available on its Investor relations website.

The Company is posting this press release and, additionally, three presentation slides that will be referenced on its webcast to its Investor Relations website.

Direct link to Earnings Release FY17 Q3:

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MzYzMjg4fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636204319995092420

Direct link to Three Presentation Slides That Will Be Referenced on the Webcast:

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MzYzMjg5fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636204319995092420

As previously announced, the Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8:00am Eastern Time on February 6, 2017. A live webcast of the call can be accessed on Haemonetics' investor relations website.

Direct link to Conference Call Webcast: http://edge.media-server.com/m/p/s6y9gqek

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

INVESTOR CONTACT:Gerry Gould, VP-Investor Relations(781) 356-9402[email protected]

MEDIA CONTACT:Sandra Jesse, Executive VP(781) 356-9253[email protected]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/haemonetics-3rd-quarter-fiscal-2017-earnings-release-available-on-investor-relations-website-300402192.html

SOURCE Haemonetics Corporation

Categories

Press Releases

Next Articles